Search Results - "Menchen, Luis"

Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits by Laserna-Mendieta, Emilio J., Salvador-Martín, Sara, Marín-Jiménez, Ignacio, Menchén, Luis A., López-Cauce, Beatriz, López-Fernández, Luis A., Lucendo, Alfredo J.

“…•Immunogenicity of infliximab and adalimumab is a problem causing loss of response.•Monitoring of anti-drug antibodies is recommended in clinical…”
Get full text

Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon inflammation induced by sub-chronic stress by Martín-Hernández, David, Gutiérrez, Irene L., González-Prieto, Marta, MacDowell, Karina S., Robledo-Montaña, Javier, Tendilla-Beltrán, Hiram, Calleja-Rodríguez, Natalia, Bris, Álvaro G., Ulecia-Morón, Cristina, Moreno, Beatriz, Caso, Javier R., García-Bueno, Borja, Rodrigues-Mascarenhas, Sandra, Marín-Jiménez, Ignacio, Leza, Juan Carlos, Menchén, Luis

“…The chronic inflammatory process that characterizes inflammatory bowel diseases (IBD) is mainly driven by T-cell response to microbial and environmental…”
Get full text

Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits by Laserna-Mendieta, Emilio J, Salvador-Martín, Sara, Arias-González, Laura, Ruiz-Ponce, Miriam, Menchén, Luis A, Sánchez, César, López-Fernández, Luis A, Lucendo, Alfredo J

“…Background Therapeutic drug monitoring (TDM) of adalimumab (ADA) in inflammatory bowel diseases (IBDs) has gained increased attention since several studies…”
Get more information

Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease by Salvador-Martín, Sara, López-Cauce, Beatriz, Nuñez, Olga, Laserna-Mendieta, Emilio J., García, María I., Lobato, Elena, Abarca-Zabalía, Judith, Sanjurjo-Saez, María, Lucendo, Alfredo J., Marín-Jiménez, Ignacio, Menchén, Luis A., López-Fernández, Luis A.

“…[Display omitted] Several factors, such as trough serum anti-TNF levels, have been associated with response to therapy in Crohn’s disease. However, this…”
Get full text

Activation of Innate Immune Defense Mechanisms by Signaling through RIG-I/IPS-1 in Intestinal Epithelial Cells by Hirata, Yoshihiro, Broquet, Alexis H, Menchen, Luis, Kagnoff, Martin F

“…Intestinal epithelial cells (IECs) are a first line of defense against microbial pathogens that enter the host through the intestinal tract. Moreover, viral…”
Get full text

Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease by Miranda-Bautista, José, Menchén, Luis

Get more information

Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing by González-Partida, Irene, Martínez-Lozano, Helena, González-Lois, Carmen, Peligros, Isabel, Sánchez-Yuste, Rosario, Salas, Isabel, Matallana, Virginia, Bighelli, Federico, Calvo, Marta, Marín-Jiménez, Ignacio, Salas, Clara, Vera, María I., Menchén, Luis, González-Lama, Yago

“…Current therapeutic goals in ulcerative colitis (UC) include clinical and endoscopic remission, named mucosal healing (MH). Despite MH, a proportion of…”
Get full text

Characteristics of inflammatory bowel disease in patients of Roma/Gypsy ethnicity. A case-control study by Cabré, Eduard, Mañosa, Míriam, Marín, Ignacio, Martín-Mateos, Rosa, Iglesias-Flores, Eva, Barreiro-de-Acosta, Manuel, Nos, Pilar, Busquets, David, Menchén, Luis A., López-Sanromán, Antonio, Domènech, Eugeni

“…Peculiarities of inflammatory bowel disease (IBD) have been explored in ethnic groups, such as Asians, Hispanics, and Afro-Americans, but not in other ethnic…”
Get full text

Systematic review with meta‐analysis: effect of inflammatory bowel disease therapy on lipid levels by Sleutjes, Jasmijn A. M., Roeters van Lennep, Jeanine E., Boersma, Eric, Menchen, Luis A., Laudes, Matthias, Farkas, Klaudia, Molnár, Tamás, Kennedy, Nicholas Alexander, Pierik, Marieke J., Woude, C. Janneke, Vries, Annemarie C.

“…Summary Background Increase in lipid levels associated with the treatment of inflammatory bowel disease (IBD) has previously been reported. However, it is…”
Get full text

Effectiveness and safety of GLP-1 agonist in obese patients with inflammatory bowel disease by Ramos Belinchón, Clara, Martínez-Lozano, Helena, Serrano Moreno, Clara, Hernández Castillo, Diego, Lois Chicharro, Pablo, Ferreira Ocampo, Pablo, Marín-Jiménez, Ignacio, Bretón Lesmes, Irene, Menchén, Luis

“…Obesity affects many patients with inflammatory bowel disease (IBD). Glucagon-like peptide (GLP)-1 agonists are a promising therapy for obese patients…”
Get full text

Clinical Approach to STRIDE-II in Real-Life Settings: Analysis and Practical Recommendations by Ricart, Elena, Bastida, Guillermo, Carpio, Daniel, Ceballos, Daniel, Ginard, Daniel, Marín-Jimenéz, Ignacio, Menchén, Luis, Muñoz, Fernando, González-Lama, Yago

“…We aimed to (1) analyze the applicability of the updated Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) recommendations in real-world…”
Get full text

Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series by Barreiro-de Acosta, Manuel, García-Bosch, Orlando, Gordillo, Jordi, Mañosa, Miriam, Menchén, Luis, Souto, Raquel, Marin-Jimenez, Ignacio

“…AIMIn refractory pouchitis, infliximab (IFX) has been used as rescue therapy; however, there is no clinical evidence for the use of adalimumab (ADA). The aim…”
Get full text

Listeria monocytogenes infection in inflammatory bowel disease patients: case series and review of the literature by Miranda-Bautista, José, Padilla-Suárez, Camilo, Bouza, Emilio, Muñoz, Patricia, Menchén, Luis, Marín-Jiménez, Ignacio

“…BACKGROUNDListeria monocytogenes (LM) is a gram-positive intracellular bacillus that in immunodeficient patients, children, geriatric patients, pregnant women,…”
Get full text

Weber-Christian disease with ileocolonic involvement successfully treated with infliximab by Miranda-Bautista, José, Fernández-Simón, Alejandro, Pérez-Sánchez, Isabel, Menchén, Luis

“…Weber-Christian disease (WCD) is an inflammatory disease whose main histological feature is lobular panniculitis of adipose tissue. The location of…”
Get full text

Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain by Taxonera, Carlos, de Andrés-Nogales, Fernando, García-López, Santiago, Sánchez-Guerrero, Amelia, Menchén, Belén, Peral, Carmen, Cábez, Ana, Gómez, Susana, López-Ibáñez de Aldecoa, Alejandra, Casado, Miguel Ángel, Menchén, Luis

“…To evaluate the cost-effectiveness of tofacitinib in comparison to vedolizumab for the treatment of moderate-to-severe ulcerative colitis (UC) after failure or…”
Get more information

Reviewing the therapeutic role of budesonide in Crohn's disease by López-Sanromán, Antonio, Clofent, Joan, Garcia-Planella, Esther, Menchén, Luis, Nos, Pilar, Rodríguez-Lago, Iago, Domènech, Eugeni

“…Oral budesonide is a glucocorticoid of primarily local action. In the field of digestive diseases, it is used mainly in inflammatory bowel disease, but also in…”
Get more information

Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn’s disease by Chaparro, María, Guerra, Iván, Iborra, Marisa, Cabriada, José Luis, Bujanda, Luis, Taxonera, Carlos, García-Sánchez, Valle, Marín-Jiménez, Ignacio, Barreiro-de Acosta, Manuel, Vera, Isabel, Martín-Arranz, María Dolores, Hernández-Breijo, Borja, Mesonero, Francisco, Sempere, Laura, Gomollón, Fernando, Hinojosa, Joaquín, Bermejo, Fernando, Beltrán, Belén, Rodríguez Pescador, Ainhoa, Banales, Jesús María, Olivares, David, Aguilar-Melero, Patricia, Menchén, Luis, Ferreiro-Iglesias, Rocío, Blazquez Gomez, Isabel, Benítez García, Belén, Guijarro, Luis González, Marin, Alicia, Bernardo, David, Gisbert, Javier P.

“…The aims of this study were (a) to know the kinetics of antitumor necrosis factor (TNF) drug serum levels during the induction phase in patients with Crohn's…”
Get full text

Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus by González-Lama, Yago, Ricart, Elena, Carpio, Daniel, Bastida, Guillermo, Ceballos, Daniel, Ginard, Daniel, Marin-Jimenez, Ignacio, Menchen, Luis, Muñoz, Fernando

“…BackgroundDespite research, there are still controversial areas in the management of Crohn’s disease (CD).ObjectiveTo establish practical recommendations on…”
Get full text

The Role of PPARγ on Restoration of Colonic Homeostasis After Experimental Stress-Induced Inflammation and Dysfunction by Ponferrada, Ángel, Caso, Javier R, Alou, Luis, Colón, Arturo, Sevillano, David, Moro, María A, Lizasoain, Ignacio, Menchén, Pedro, Gómez–Lus, María L, Lorenzo, Pedro, Cos, Enrique, Leza, Juan C, Menchén, Luis

“…Background & Aims: Psychological stress has been implicated in the clinical course of several gastrointestinal diseases, but the mechanisms implicated and the…”
Get full text

Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn study by Barreiro-De Acosta, Manuel, Domènech, Eugeni, Martín Arranz, María Dolores, García Sánchez, Valle, Gutiérrez Casbas, Ana, Chaparro, María, Alcain, Guillermo, Iborra, Marisa, Taxonera, Carlos, Rodriguez-Lago, Iago, Menchén, Luis, Khorrami, Sam, Romero, Cristina, Cea-Calvo, Luis, Juliá, Berta

“…: In patients with Crohn's disease (CD), endoscopic recurrence precedes clinical recurrence after ileocolonic resection. Guidelines recommend ileocolonoscopy…”
Get more information